NR4A1 and breast cancer: For postmenopausal women with EBC, the risk of abnormal TC and LDL-C was also higher in the AI group than in the SERM group, which was consistent with the clinical reports of early hormone receptor-positive BC patients treated with endocrine therapy (13, 24–26).